These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 15173029)

  • 1. G(-30)A polymorphism in the pancreatic promoter of the glucokinase gene associated with angiographic coronary artery disease and type 2 diabetes mellitus.
    März W; Nauck M; Hoffmann MM; Nagel D; Boehm BO; Koenig W; Rothenbacher D; Winkelmann BR
    Circulation; 2004 Jun; 109(23):2844-9. PubMed ID: 15173029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The angiotensin-I converting enzyme I/D polymorphism is not associated with type 2 diabetes in individuals undergoing coronary angiography. (The Ludwigshafen Risk and Cardiovascular Health Study).
    Grammer TB; Renner W; von Karger S; Boehm BO; Winkelmann BR; Maerz W
    Mol Genet Metab; 2006 Aug; 88(4):378-83. PubMed ID: 16765625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin converting enzyme insertion/deletion (I/D) (rs4646994) and Vegf polymorphism (+405G/C; rs2010963) in type II diabetic patients: Association with the risk of coronary artery disease.
    Moradzadegan A; Vaisi-Raygani A; Nikzamir A; Rahimi Z
    J Renin Angiotensin Aldosterone Syst; 2015 Sep; 16(3):672-80. PubMed ID: 24505095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Association of the hepatic lipase gene -250G/A promoter polymorphism with the susceptibility to type 2 diabetes mellitus combining with coronary heart disease].
    Wei M; Lu YS; Li PP
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Apr; 26(2):219-22. PubMed ID: 19350521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients.
    Vaisi-Raygani A; Rahimi Z; Nomani H; Tavilani H; Pourmotabbed T
    Clin Biochem; 2007 Oct; 40(15):1150-6. PubMed ID: 17689519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptor 4 gene Asp299Gly polymorphism is associated with reductions in vascular inflammation, angiographic coronary artery disease, and clinical diabetes.
    Kolek MJ; Carlquist JF; Muhlestein JB; Whiting BM; Horne BD; Bair TL; Anderson JL
    Am Heart J; 2004 Dec; 148(6):1034-40. PubMed ID: 15632890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alanine to serine polymorphism at position 986 of the calcium-sensing receptor associated with coronary heart disease, myocardial infarction, all-cause, and cardiovascular mortality.
    März W; Seelhorst U; Wellnitz B; Tiran B; Obermayer-Pietsch B; Renner W; Boehm BO; Ritz E; Hoffmann MM
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2363-9. PubMed ID: 17374704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The common -866G>A variant in the promoter of UCP2 is associated with decreased risk of coronary artery disease in type 2 diabetic men.
    Cheurfa N; Dubois-Laforgue D; Ferrarezi DA; Reis AF; Brenner GM; Bouché C; Le Feuvre C; Fumeron F; Timsit J; Marre M; Velho G
    Diabetes; 2008 Apr; 57(4):1063-8. PubMed ID: 18192542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of the impact of a liver glucokinase promoter variant on glucose tolerance and insulin sensitivity index.
    Urhammer SA; Hansen T; Jensen LB; Clausen JO; Hansen L; Chui KC; Pedersen O
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1786-9. PubMed ID: 9177383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The -30G>A polymorphism of the glucokinase gene promoter is associated with obesity in a population from southern Spain.
    Gómez-Zumaquero JM; Rojo-Martínez G; García-Escobar E; Martín-Nuñez GM; Haro J; Esteva I; Ruiz de Adana M; Cuesta AL; Olveira G; Morcillo S; Soriguer F
    Obesity (Silver Spring); 2008 Aug; 16(8):1973-5. PubMed ID: 18483479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of obesity and type 2 diabetes with tumor necrosis factor-α 308G/A gene polymorphism in metabolic syndrome and coronary artery disease subjects.
    Sobti RC; Kler R; Sharma YP; Talwar KK; Singh N
    Mol Cell Biochem; 2012 Jan; 360(1-2):1-7. PubMed ID: 22081334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interleukin-6 G(-174)C promoter polymorphism in the LURIC cohort: no association with plasma interleukin-6, coronary artery disease, and myocardial infarction.
    Nauck M; Winkelmann BR; Hoffmann MM; Böhm BO; Wieland H; März W
    J Mol Med (Berl); 2002 Aug; 80(8):507-13. PubMed ID: 12185451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemokine receptor 5 (CCR5) deletion polymorphism in North Indian patients with coronary artery disease.
    Sharda S; Gilmour A; Harris V; Singh VP; Sinha N; Tewari S; Ramesh V; Agrawal S; Mastana S
    Int J Cardiol; 2008 Feb; 124(2):254-8. PubMed ID: 17383752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. rs10865710 polymorphism in PPARG promoter is associated with the severity of type 2 diabetes mellitus and coronary artery disease in a Chinese population.
    Song Y; Raheel TM; Jia A; Dai G; Liu L; Long X; He C
    Postgrad Med J; 2022 Oct; 98(1164):778-787. PubMed ID: 37062988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics of Japanese men with glucokinase gene beta-cell promoter variant.
    Yamada K; Yuan X; Ishiyama S; Ichikawa F; Koyama KI; Koyanagi A; Koyama W; Nonaka K
    Diabetes Care; 1997 Jul; 20(7):1159-61. PubMed ID: 9203455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of the platelet glycoprotein IIIa PlA1/A2 gene polymorphism to coronary artery disease but not to nonfatal myocardial infarction in low risk patients.
    Gardemann A; Humme J; Stricker J; Nguyen QD; Katz N; Philipp M; Tillmanns H; Hehrlein FW; Rau M; Haberbosch W
    Thromb Haemost; 1998 Aug; 80(2):214-7. PubMed ID: 9716139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between cholesteryl ester transfer protein TaqIB variants and risk of coronary artery disease and diabetes mellitus in the population of western Iran.
    Rahimi Z; Nourozi-Rad R; Vaisi-Raygani A; Saidi MR; Rahimi Z; Ahmadi R; Yarani R; Hamzehee K; Parsian A
    Genet Test Mol Biomarkers; 2011 Nov; 15(11):813-9. PubMed ID: 21689002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The C allele of the reactive oxygen species modulator 1 (ROMO1) polymorphism rs6060566 is a biomarker predicting coronary artery stenosis in Slovenian subjects with type 2 diabetes mellitus.
    Tibaut M; Mankoč Ramuš S; Petrovič D
    BMC Med Genomics; 2020 Dec; 13(1):184. PubMed ID: 33302957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The beta cell glucokinase promoter variant is an unlikely risk factor for diabetes mellitus. Diabetes Incidence Study in Sweden (DISS).
    Lotfi K; Sund G; Lowe R; Graham J; Landin-Olsson M; Kockum I; Deeb S; Lernmark A
    Diabetologia; 1997 Aug; 40(8):959-62. PubMed ID: 9267992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of the genetic variants of endothelial nitric oxide synthase gene with angiographically defined coronary artery disease and myocardial infarction in South Indian patients with type 2 diabetes mellitus.
    Narne P; Ponnaluri KC; Singh S; Siraj M; Ishaq M
    J Diabetes Complications; 2013; 27(3):255-61. PubMed ID: 23182401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.